SMMT.O (SMMT.O) News
Track canonical SquawkNews coverage tagged to SMMT.O, SMMT.O. This hub brings together deduplicated headlines about market instrument, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 2 indexed stories across 1 publication days and is ordered by the same first-publication timeline used by LiveCast.
M
AstraZeneca to invest $2 billion in Summit Therapeutics for cancer drug tie-up
Summit said AstraZeneca will buy preferred shares at an equivalent $18.36 a share and the transaction is expected to close by week-end.
MNA | Sep 28, 2026, 10:10 PM UTC
M
AstraZeneca to invest $2 billion in Summit Therapeutics
The companies also agreed to a clinical trial collaboration to evaluate ivonescimab with sonesitatug vedotin in gastrointestinal cancers. Summit said AstraZeneca’s investment will be in convertible preferred shares.
MNA | Sep 28, 2026, 09:30 PM UTC